{"product_id":"ulcerative-colitis-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Ulcerative Colitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eUlcerative Colitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview:\u003c\/p\u003e\n\n\u003cp\u003eThe global ulcerative colitis market size reached US$ 7.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eUlcerative colitis (UC) refers to a chronic inflammatory bowel disease (IBD) that causes irritation, inflammation, and ulcers (sores) in the digestive tract. It typically affects the inner lining of the large intestine (or colon) and rectum. The symptoms generally develop over time, and individuals diagnosed with UC may experience periods of mild or no symptoms. However, it can sometimes lead to debilitating or life-threatening complications. While there is no cure for UC yet, the treatment can help patients manage and reduce their symptoms, prevent flare-ups, and bring about long-term remission. As a result, UC treatment is rapidly gaining traction across the globe as it can help enhance the quality of life and ensure the physical and mental wellbeing of the patients.\u003c\/p\u003e\n\n\u003cp\u003eUlcerative Colitis Market Trends:\u003cbr\u003e\nThe widespread prevalence of UC disease and the rising awareness regarding the available treatment options represent the primary factors driving the market growth. Besides this, the presence of strong pipeline products and continuous advancements in numerous drugs are augmenting the product demand. Additionally, governments of various countries are taking several initiatives to spread awareness about the condition and enhance the accessibility and availability of proper healthcare facilities. This, in confluence with the increasing investments in the research and development (R\u0026amp;D) activities for the development of novel therapies, is propelling the market growth. Furthermore, the leading players are focusing on launching innovative and more effective drugs to expand their product portfolio and gain a competitive edge in the market. Other factors, including the easy availability of biosimilar drugs, improving healthcare infrastructure, favorable reimbursement policies, and increasing consumer spending on healthcare, are also creating a positive market outlook.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global ulcerative colitis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease type, molecule type, drug type, route of administration and distribution channel.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Type:\u003c\/p\u003e\n\n\u003cp\u003eMild UC\u003cbr\u003e\nModerate UC\u003cbr\u003e\nSevere UC\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Disease Type:\u003c\/p\u003e\n\n\u003cp\u003eUlcerative Proctitis\u003cbr\u003e\nProctosigmoiditis\u003cbr\u003e\nLeft-sided Colitis\u003cbr\u003e\nPancolitis or Universal Colitis\u003cbr\u003e\nFulminant Colitis\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Molecule Type:\u003c\/p\u003e\n\n\u003cp\u003eSmall Molecules\u003cbr\u003e\nBiologics\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Drug Type:\u003c\/p\u003e\n\n\u003cp\u003eAnti-Inflammatory Drugs\u003cbr\u003e\nAnti-TNF Biologics\u003cbr\u003e\nImmunosuppressant\u003cbr\u003e\nCalcineurin Inhibitors\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Route of Administration:\u003c\/p\u003e\n\n\u003cp\u003eOral\u003cbr\u003e\nInjectable\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Distribution Channel:\u003c\/p\u003e\n\n\u003cp\u003eHospital Pharmacies\u003cbr\u003e\nRetail Pharmacies\u003cbr\u003e\nDrug Store\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia-Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\n \u003cbr\u003e\nCompetitive Landscape:\u003cbr\u003e\nThe competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson \u0026amp; Johnson, Merck \u0026amp; Co. Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003cbr\u003e\nHow has the global ulcerative colitis market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global ulcerative colitis market?\u003cbr\u003e\nWhat are the key regional markets?\u003cbr\u003e\nWhat is the breakup of the market based on the type?\u003cbr\u003e\nWhat is the breakup of the market based on the disease type?\u003cbr\u003e\nWhat is the breakup of the market based on the molecule type?\u003cbr\u003e\nWhat is the breakup of the market based on the drug type?\u003cbr\u003e\nWhat is the breakup of the market based on the route of administration?\u003cbr\u003e\nWhat is the breakup of the market based on the distribution channel?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global ulcerative colitis market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"September, 2023 \/ 146 Pages \/ MCW16232336","offer_id":47647493292338,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/ulcerative-colitis-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}